Loading...
Domestic
Equity
Passive

KBSTAR Healthcare (253280)

Update : 2023.02.03

NAV

10,606KRW

+112.05상승 (1.07%)

Market Price per share (KRW)

10,635KRW

+170상승 (1.62%)

※ t-1 last price

trading volume

4,172shares

AUM

KRW 5.3billion

KBSTAR Healthcare (253280)

KEY POINT

Invest in domestic healthcare companies (medical equipment and services, bio, pharmaceutical)

KEY POINT

Invest in selected healthcare companies based on financial conditions among the top 500 companies by market capitalization of the KOSPI and KOSDAQ markets

Basic information

Download trading information

Update : 2023.02.03
ETF name(Code), Benchmark Index, Inception date, creation unit, Net Asset (KRW 0.1 billion), Trustee, Rule of Dividend payment, Market Price per share (KRW), iNAV per share (KRW), trading volume (share), Total Expense ratio table
ETF Name (code) Benchmark Index Inception date Creation Unit AUM (KRW)
KB KStar V&S Select ValueETF(Equity)
(253280)
FnGuide HealthCare Index 2016.09.23 50,000 5,302,976,026
Trustee Market Price per share (KRW) NAV Trading Volume (shares)
하나은행 10,635
※ t-1 last price
10,605 4,172
authorized participant, Liquidity provider table
Total Expense Ratio Distribution Frequency 다운로드 버튼
Year 0.05% (Designated participating company : 0.001%, Collective investment : 0.029%, trust : 0.01%, General affairs : 0.01%) Last business day of January, April, July and October, and end of accounting period (occasional payment)
Authorized Participants Liquidity Providers
KB Securities, Meritz Securities, NH Investment & Securities, Kiwoom Securities, Samsung Securities KB Securities, Meritz Securities, NH Investment & Securities, Kiwoom Securities, Samsung Securities
ETF name(Code), Benchmark Index, Inception date, creation unit, AUM(0.1 billion) (KRW), Trustee, Rule of Dividend payment, Market Price per share (KRW), iNAV per share (KRW), trading volume (share), Total Expense ratio table
ETF Name(Code) Benchmark Index
KB KStar V&S Select ValueETF(Equity)

(253280)
FnGuide HealthCare Index
Inception date Creation Unit
2016.09.23 50,000
AUM(0.1 billion) (KRW) Trustee
5,302,976,026 하나은행
Market Price per share (KRW) iNAV per share (KRW)
10,635
※ t-1 last price
10,605
Trading Volume (shares)
4,172
authorized participant, Liquidity provider table
Total Expense Ratio
Year 0.05% (Designated participating company : 0.001%, Collective investment : 0.029%, trust : 0.01%, General affairs : 0.01%)
Distribution Frequency
Last business day of January, April, July and October, and end of accounting period (occasional payment)
Authorized Participants
KB Securities, Meritz Securities, NH Investment & Securities, Kiwoom Securities, Samsung Securities
Liquidity Providers
KB Securities, Meritz Securities, NH Investment & Securities, Kiwoom Securities, Samsung Securities

Index Introduction

The FnGuide Healthcare Index is a market capitalization weighted index. The index selects stocks that satisfy financial and management soundness criteria out of the universe of stocks come under the medical sector in the MKF 500.

View detailed index information

TOP 10 Holdings

Update : 2023-02-03
Rank , Name, proportion table
Rank Name Weight (%)
1 Celltrion 9.77
2 SAMSUNG BIOLOGICS 9.65
3 Celltrion Healthcare 9.58
4 HLB 8.70
5 Yuhan 7.16
6 HanmiPharm 5.08
7 SKBP 4.99
8 SKBS 4.21
9 Celltrionph 3.04
10 SD Biosensor 2.66

proportion by sectors

*The proportion of investment stocks

Update : 2023.02.03
Rank , Name, proportion table
Rank Name Weight (%)
1 Healthcare 100.00

Dividend payment data

· Payable date of dividend payment 3 years.
Rule of Dividend payment, Payable date of dividend payment, dividend per share (KRW) table
Rule of Dividend payment Payable date of dividend payment dividend per share (KRW)
2022-04-29 2022-05-03 60
2021-04-30 2021-05-04 71
2020-04-29 2020-05-06 46

Performance

performance

excel download

Update : 2023-02-03

 (as of Oct : %)

The result of above Net Asset Value performance is the rate of return assuming distribution reinvestment.

classification, 1Month, 3Month, 6Month, 1year, 3year, YTD (Year to date), Since inception, NAV, Benchmark Index, Outperformance table
classification 1Month 3Month 6Month 1year 3year YTD
(Year to date)
Since
inception
NAV 3.86 -0.31 -10.17 -9.00 16.76 2.28 4.27
Benchmark Index 3.94 -0.70 -10.75 -9.23 16.65 2.33 4.74
Outperformance -0.09 0.38 0.58 0.23 0.11 -0.06 -0.48

daily Performance

excel download

date, market price (KRW), NAV (KRW)
date Market price (KRW) NAV (KRW)
closing price Daily Return(%) closing price Daily Return(%)
2023.02.02 10,635 1.624상승 10,493.9 2.287상승
2023.02.01 10,465 1.849상승 10,259.27 -0.688하락
2023.01.31 10,275 -0.580하락 10,330.35 -1.640하락
2023.01.30 10,335 -1.571하락 10,502.69 -
2023.01.27 10,500 1.253상승 10,415.81 0.509상승
2023.01.26 10,370 0.144상승 10,363.05 0.580상승
2023.01.25 10,355 0.778상승 10,303.2 -
2023.01.20 10,275 -0.484하락 10,338.3 1.022상승
2023.01.19 10,325 0.830상승 10,233.7 -0.142하락
2023.01.18 10,240 -0.146하락 10,248.29 -2.248하락
2023.01.17 10,255 -1.866하락 10,484.02 0.175상승
2023.01.16 10,450 -0.191하락 10,465.64 -
2023.01.13 10,470 - 10,489.69 0.523상승
2023.01.12 10,470 0.287상승 10,435.06 1.491상승
2023.01.11 10,440 1.704상승 10,281.72 -1.718하락
2023.01.10 10,265 -1.770하락 10,461.49 1.649상승
2023.01.09 10,450 2.000상승 10,291.75 -
2023.01.06 10,245 0.490상승 10,176.1 0.474상승
2023.01.05 10,195 0.890상승 10,128.08 0.211상승

Holdings

Name, Ticker, Number. of shares, Weight(%), market price (KRW)
No. (Number) Name Ticker Number of shares
/ Par value
Weight(%) Market price (KRW)
1 Celltrion KR7068270008 306 9.77 51,836,400
2 SAMSUNG BIOLOGICS KR7207940008 63 9.65 51,156,000
3 Celltrion Healthcare KR7091990002 836 9.58 50,828,800
4 HLB KR7028300002 1,437 8.7 46,127,700
5 Yuhan KR7000100008 711 7.16 37,967,400
6 HanmiPharm KR7128940004 99 5.08 26,928,000
7 SKBP KR7326030004 362 4.99 26,462,200
8 SKBS KR7302440003 282 4.21 22,334,400
9 Celltrionph KR7068760008 242 3.04 16,117,200
10 SD Biosensor KR7137310009 482 2.66 14,122,600
11 SEEGENE KR7096530001 483 2.54 13,475,700
12 Hanmi Science KR7008930000 362 2.16 11,475,400
13 ST Pharm KR7237690003 133 2.07 10,985,800
14 DENTIUM KR7145720009 87 1.86 9,839,700
15 GC Corp KR7006280002 73 1.86 9,869,600
16 ShinpoongPharm KR7019170000 440 1.8 9,526,000
17 MedyTox KR7086900008 69 1.79 9,494,400
18 SCD KR7000250001 180 1.73 9,162,000
19 DAEWOONG PHARM KR7069620003 60 1.7 9,036,000
20 원화예금 KRD010010001 9,016,752 1.7 9,016,752
21 BIONEER KR7064550007 295 1.56 8,289,500
22 HANALL BIOPHARMA KR7009420001 469 1.48 7,869,820
23 CHA Biotech KR7085660009 528 1.45 7,703,520
24 HK inno.N KR7195940002 193 1.45 7,710,350
25 Lutronic KR7085370005 276 1.19 6,306,600
26 PharmaResearch KR7214450009 80 1.18 6,248,000
27 Jeisys Medical KR7287410005 660 1.14 6,052,200
28 ILDONG PHARM KR7249420001 215 1.05 5,590,000
29 HUMASIS KR7205470008 392 1.05 5,566,400
30 GC CELL KR7144510005 105 0.98 5,187,000
31 YUNGJIN PHARM KR7003520004 1,194 0.82 4,364,070
32 CLASSYS KR7214150005 229 0.81 4,300,620
33 Boryung KR7003850005 392 0.73 3,857,280
34 KUP KR7033270000 119 0.53 2,808,400
35 KUKJEON KR7307750000 254 0.31 1,653,540
36 KOREA PHARMA KR7032300006 45 0.19 1,028,250
Investment notice
- The information provided on this website is based on reliable sources, but its accuracy and completeness are not guaranteed.
- Financial investment products are not protected by the Korea Deposit Insurance Corporation in accordance with the Depositor Protection Act, and a loss of investment principal may occur, which belongs to the investor.
- Past performance does not guarantee future profits.
- In the case of a collective investment scheme that invests in foreign securities, asset values may be lost due to risks caused by market, political, and economic conditions in the target country.
- Derivatives may lose all or a significant portion of the investment principal in a short period of time due to high price volatility, and there is a risk that the counterparty may not be able to fulfill the terms of the contract when investing in over-the-counter derivatives.
- Before investing, be sure to read the investment prospectus and contract recommendation document regarding the investment subject, redemption method, and fee.